NAMPT and endothelial dysfunction: This impairment is reversed by either the NADPH oxidase inhibitor apocynin or by the nicotinamide phosphoribosyl transferase inhibitor APO866 but not by an insulin receptor-blocking antibody, suggesting that visfatin-induced endothelial dysfunction occurs via a NAMPT/NADPH pathway [252].